CLINICAL_TRIALS
trial_result
· 2010-03-03
Clinical Trial Update: A Study With OPTIVATE® in People With Von Willebrand Disease [Phase 3]
Summary
A Phase 3 clinical trial of OPTIVATE in people with Von Willebrand Disease was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bio Products Laboratory | Conditions: Von Willebrand Disease | Phase 3 | Status: TERMINATED